Trends in Molecular Medicine

Papers
(The median citation count of Trends in Molecular Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Advisory Board and Contents401
Advisory Board and Contents251
Subscription and Copyright Information207
The emerging regulatory interface between DNA repair and steroid hormone receptors in cancer203
Gene therapies for neurogenetic disorders182
Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin173
PD-L1 at the crossroad between RNA metabolism and immunosuppression165
Considerations for capsid-targeting antiretrovirals in pre-exposure prophylaxis155
Unleashing cell-penetrating peptide applications for immunotherapy134
Translating osteoarthritis genetics research: challenging times ahead116
The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2106
Preventing unfolded protein response-induced ion channel dysregulation to treat arrhythmias102
Advisory Board and Contents101
Bringing vascularization into glioblastoma in vitro models96
Subscription and Copyright Information94
Advisory Board and Contents90
Advisory Board and Contents88
Advisory Board and Contents84
Advisory Board and Contents78
Stories in Molecular Medicine April 202172
Subscription and Copyright Information71
Stories in Molecular Medicine December 202171
Subscription and Copyright Information69
Stories in Molecular Medicine September 202169
Subscription and Copyright Information68
Advisory Board and Contents65
Subscription and Copyright Information63
Advisory Board and Contents63
Advisory Board and Contents60
Advisory Board and Contents60
Subscription and Copyright Information59
Subscription and Copyright Information58
Cutaneous neuroimmune crosstalk in pruritus54
Organoids, Where We Stand and Where We Go54
Convalescent plasma to deliver therapeutic antibodies against COVID-1954
Advisory Board and Contents51
Vascular dysfunction in Hutchinson–Gilford progeria syndrome50
Meeting the needs of patients with ultrarare diseases50
Post-acute anti-NMDAR encephalitis mirrors schizophrenia50
Bursts of brain erosion: seizures and age-dependent neurological vulnerability49
Targeting CDK2 to circumvent treatment resistance in HR+ breast cancer46
Subscription and Copyright Information45
Microbiome-targeted interventions for the control of oral–gut dysbiosis and chronic systemic inflammation45
Beyond the danger signal: RNA aggregates orchestrate immunotherapy42
COVID-19 in pregnancy: implications for fetal brain development42
Glycosylation of blood cells during the onset and progression of atherosclerosis and myocardial infarction42
Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors42
Unmasking BACE1 in aging and age-related diseases40
Consideration of the importance of measuring thermal discomfort in biomedical research39
PROT3EcT, engineered Escherichia coli for the targeted delivery of therapeutics39
Opportunities and challenges for biomarker discovery using electronic health record data39
Targeting PERK to treat arrhythmias39
TIM-3 blockade: immune and targeted therapy in DIPG38
Neutrophils and extracellular traps in crystal-associated diseases38
mRNA vaccine platforms to prevent bacterial infections38
RyR-mediated calcium release in hippocampal health and disease38
Vitiligo: advances in pathophysiology research and treatment development38
TIM-3 inhibitors: a promising strategy for tumor immunotherapy37
Challenges and opportunities for conceiving genetically diverse sickle cell mice36
Neuroendocrine insights into neurosteroid therapy for postpartum depression36
Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy35
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies35
Cellular senescence in neuroinflammatory disease: new therapies for old cells?35
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates34
Control of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Cancer34
A cryptic mode of GPCR regulation revealed33
Imaging genomics: data fusion in uncovering disease heritability32
Science around the world32
Suicide prevention in cancer: earlier is better32
Subscription and Copyright Information32
SARS-CoV-2 targets the liver and manipulates glucose metabolism32
Breakthroughs and bottlenecks in autophagy research32
Advisory Board and Contents32
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies31
Advisory Board and Contents30
m6A and beyond: RNA modifications shaping angiogenesis30
Vaccine-based immunotherapy and related preclinical models for glioma29
Understanding the tuberculosis granuloma: the matrix revolutions28
Molecular therapy for polyQ disorders: from bench to clinical trials27
Ancestry, ethnicity, and race: explaining inequalities in cardiometabolic disease27
Homeostatic maintenance of the lymphatic vasculature27
Beneath the radar: immune-evasive cell sources for stroke therapy27
Subscription and Copyright Information27
AAV capsid design: A Goldilocks challenge27
A sex-biased target against demyelination in Alzheimer’s disease26
Particulate matter and Alzheimer’s disease: an intimate connection26
Fc-optimized checkpoint antibodies for cancer immunotherapy26
Bridging rapid and sustained antidepressant effects of ketamine26
Polycystic kidney disease: novel insights into polycystin function25
Alternative splicing: a bridge connecting NAFLD and HCC25
Resistance exercise for anxiety and depression: efficacy and plausible mechanisms24
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes24
Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines24
The variant landscape and function of DDX3X in cancer and neurodevelopmental disorders24
The physiology of bilirubin: health and disease equilibrium24
CXCR2 chemokine receptor – a master regulator in cancer and physiology24
d-Amino acids: new clinical pathways for brain diseases23
Pushing the boundaries of brain organoids to study Alzheimer’s disease23
Asthma exacerbations: the Achilles heel of asthma care23
Hidden mysteries behind genome, epigenome, and exposome of lupus erythematosus22
Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges22
Circular RNA translation: novel protein isoforms and clinical significance22
HPV integration and cervical cancer: a failed evolutionary viral trait22
Microbiota and sleep: awakening the gut feeling22
Autoimmune diseases and cardiovascular risk22
Dietary interventions and precision nutrition in cancer therapy22
Tackling ‘lost in translation’ issues: a response to Perez-Campos et al.21
Staging of Alzheimer’s disease: past, present, and future perspectives21
New strategies for the treatment of chronic hepatitis B21
Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation21
Subscription and Copyright Information21
Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies21
Subscription and Copyright Information20
Subscription and Copyright Information20
Three ‘E’ challenges for siRNA drug development20
Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies20
Advisory Board and Contents20
Thirty years of molecular medicine: reflections from an academic physician-scientist, 1995–202519
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects19
Subscription and Copyright Information19
Engineering cytokines for tumor-targeting and selective T cell activation19
Emerging roles of cyclin-dependent kinase 7 in health and diseases19
Beyond memory impairment: the complex phenotypic landscape of Alzheimer’s disease18
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models18
Strategies to Identify Genetic Variants Causing Infertility18
Dysregulation of deubiquitinylases: a linchpin of gastrointestinal diseases18
Subscr+copyr18
Missing links in preeclampsia cell model systems of endothelial dysfunction17
Role and therapeutic implications of protein glycosylation in neuroinflammation17
Can we provide quality #MedEd on social media?17
Why we must fight ignorance about COVID-19 vaccines and menstrual cycles17
Advisory Board and Contents17
Tertiary lymphoid structures in the central nervous system17
CircRNA perspective: new strategies for RNA therapy17
How hypocretin agonists may improve the quality of wake in narcolepsy16
Stories in Molecular Medicine November 202116
Brain-specific regulatory T cell expansion limits cognitive decline16
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality16
β2ARs: double edge sword in heart function16
Stories in Molecular Medicine October 202116
Advisory Board and Contents16
A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies16
Fibrodysplasia ossificans progressiva emerges from obscurity15
Deep learning for subtyping the Alzheimer’s disease spectrum15
The inaccessible road to science for people with disabilities15
Microbes and mood: innovative biomarker approaches in depression15
Subscription and Copyright Information15
Copy number alterations: a catastrophic orchestration of the breast cancer genome15
In Utero Gene Therapy: Progress and Challenges14
Post-Transcriptional Regulation in Skeletal Muscle Development, Repair, and Disease14
Improving participant representation in the era of digital clinical studies14
Advisory Board and Contents14
If it ain’t broke, break it: facilitating antigen cross-presentation14
Data-Driven Modeling of Pregnancy-Related Complications14
Monoamines' role in islet cell function and type 2 diabetes risk14
Organ-specific aging in the plasma proteome predicts disease13
Harnessing the healing power of love13
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients13
Science around the world13
Insights from HIV-1 vaccine and passive immunization efficacy trials13
Breakthroughs and Bottlenecks in Microbiome Research13
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers13
Targeting monoamine oxidases in cancer: advances and opportunities13
Circadian phase instability in bipolar disorder: a neglected essence13
Engineering Strategies for Allogeneic Solid Tissue Acceptance13
Hormesis as an adaptive response to infection13
Oligodendrocyte pathology in Huntington’s disease: from mechanisms to therapeutics13
Science around the world13
Anorexia nervosa: diagnostic, therapeutic, and risk biomarkers in clinical practice12
Molecular mechanisms in the pathogenesis of dengue infections12
Treating Niemann-Pick C lysosomal storage: approved and emerging approaches12
The dual role of the TSC complex in cancer12
iPSCs and DRGs: stepping stones to new pain therapies12
Erythropoietic protoporphyrias: updates and advances12
Amyloid and collagen templates in aortic valve calcification12
Cell-free circulating tumor DNA profiling in cancer management12
Advisory Board and Contents12
There is nothing as inconsistent as the OSFED diagnostic criteria12
COVID-19 vaccines in pregnancy11
IBD disease-modifying therapies: insights from emerging therapeutics11
FSP1: a key regulator of ferroptosis11
Extracellular matrix-based cancer targeting11
Moyamoya disease emerging as an immune-related angiopathy11
Communicating science and protecting scientists in a time of political instability11
Senescence and tissue fibrosis: opportunities for therapeutic targeting11
The molecular underpinnings of female predominance in lupus11
Unlocking the potential of agonist antibodies for treating cancer using antibody engineering11
Thymic stroma and TFII-I: towards new targeted therapies11
N6-methyladenosine-mediated gene regulation and therapeutic implications11
Epigenetic regulation in intervertebral disc degeneration10
Cancer quiescence: non-coding RNAs in the spotlight10
Dysfunctional tRNA reprogramming and codon-biased translation in cancer10
Epigenetic priming in neurodevelopmental disorders10
Redefining metalloproteases specificity through network proteolysis10
Primary cilia shape hallmarks of health and aging10
Telomere biology disorders: time for moving towards the clinic?10
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging9
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?9
Eating disorders and obesity: bridging clinical, neurobiological, and therapeutic perspectives9
Molecular links between allergy and cancer9
Common mechanisms in pediatric acute liver failure9
Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology9
Host-informed therapies for the treatment of pneumococcal pneumonia9
Readthrough compounds for nonsense mutations: bridging the translational gap8
Amphiphysin-2 (BIN1) functions and defects in cardiac and skeletal muscle8
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation8
Bioelectronic medicine potentiates endogenous NSCs for neurodegenerative diseases8
Molecular pathology of rare progeroid diseases8
Targeting ACC for NASH resolution8
Trained immunity-related vaccines: innate immune memory and heterologous protection against infections8
Leptin and male fertility: unraveling the molecular pathways, receptor functions, and therapeutic potential8
Leveraging insights from cancer to improve tuberculosis therapy8
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease8
The gut vascular barrier: a new player in the gut–liver–brain axis8
Advisory Board and Contents8
Helicobacter pylori-induced NF-κB: trailblazer for gastric pathophysiology7
Genetically modified malaria parasites as vaccine candidates7
Subscr+copyr7
Advisory Board and Contents7
Fruitful Futures for Reproductive Health7
Primary B cell engineering for therapeutic research7
Clinical implications of vitamin B12 as redox-active cofactor7
Shining a light on comorbidities7
Responding to the ripple effects of sexual harassment: an emergency management framework7
Advisory Board and Contents7
Fatty acid binding proteins in multiple myeloma7
Is there a place for engineered immune cell therapies in autoimmune diseases?7
TBCK syndrome: a rare multi-organ neurodegenerative disease7
Advisory Board and Contents7
Subscription and Copyright Information7
Advisory Board and Contents7
Advisory Board and Contents7
Galectin-3 in metabolic disorders: mechanisms and therapeutic potential6
3-O-acylated bile acids: disrupters or harmonizers of metabolism?6
Clinical Potential of Kisspeptin in Reproductive Health6
Cells of the tumor microenvironment speak the Wnt language6
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines6
LDL-C augments whereas HDL-C prevents inflammatory innate immune memory6
SOX17: escape route from immune destruction in early CRC6
Multiomics tools for improved atherosclerotic cardiovascular disease management6
InFUSing antisense oligonucleotides for treating ALS6
Compartmentalization and regulation of GTP in control of cellular phenotypes6
Secondary failure: immune responses to approved protein therapeutics6
Dynamic rewiring of neurovasculature in health and disease6
Bringing gene therapy to where it’s needed6
Beyond pluripotency: Yamanaka factors drive brain growth and regeneration6
Interrogating the promise of long-acting HIV pre-exposure prophylaxis6
Topical Microbial Therapeutics against Respiratory Viral Infections6
Strategies and challenges for non-viral delivery of non-coding RNAs to the heart6
Advisory Board and Contents6
0.16209197044373